Trial studying safety and effects for Hiv
Official title Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men
ClinicalTrials.gov ID: NCT05678556
What this study is testing
- What it's testing
- This study aims to find out if an updated relationship education and HIV prevention program works better than no program at all.
- Who it's for
- The study is looking for gay, bisexual, queer, and transgender or non-binary people who have partners who are cisgender men.
- What's involved
- Participants will take part in the prevention program, complete online surveys, and get tested for HIV, chlamydia, and gonorrhea.
- Time commitment
- The study lasts for 2 years and is done entirely online, so you never need to visit a lab.
- Time commitment: about 2 years
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 34. Healthy volunteers may be eligible.
You may be able to join if
- Cisgender men, transgender women and men, non-binary individuals
- Had condomless anal sex with 2 or more serodiscordant/unknown-status cisgender male partners in the last 6 months
- Aged 16-34 years
- Lab-test confirmed HIV-negative
- Read and speak English at 8th grade level or better
You likely can't join if
- -Participants assigned female at birth who identify as women are not eligible
See the full eligibility criteria
- Cisgender men, transgender women and men, non-binary individuals
- Had condomless anal sex with 2 or more serodiscordant/unknown-status cisgender male partners in the last 6 months
- Aged 16-34 years
- Lab-test confirmed HIV-negative
- Read and speak English at 8th grade level or better
- Internet access
- Agree to audio recording of intervention sessions
- Provides address to receive HIV/STI test supplies
- For dyads, both partners may enroll if they meet the above criteria- partners who are aged 35+ and/or HIV-positive may enroll in a more limited capacity
- -Participants assigned female at birth who identify as women are not eligible
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Compensation & support
This study's listing mentions compensation or reimbursement.
No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 2 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 34 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.